77

Heron Neutron Medical Corp. (7799)

TWSE

Currency in TWD
356.50
+1.50 (+0.42%)

Closed

Aug 25, 2026

Day's Range

350.50
359.00

52 wk Range

300.00
932.00

Profile - 7799 - Heron Neutron Medical Corp.

Profile

Mic Code

XTAI

Sector

Healthcare

Industry

Medical Devices

Employees

104


Heron Neutron Medical Corp. is a healthcare technology company specializing in the development, manufacture, and integration of advanced medical equipment, with a primary focus on accelerator-based boron neutron capture therapy (AB-BNCT) systems. These solutions are designed for precise, effective cancer treatment, leveraging innovations in neutron source targets, accelerators, beam shaping, treatment control, and planning technologies. A distinguishing feature of Heron Neutron Medical Corp. is its position as a comprehensive solution provider: the company not only develops AB-BNCT devices but also integrates boron-containing therapeutic agents, enabling it to offer coordinated device-and-drug solutions to hospitals and research institutions. This integrated approach aims to improve clinical efficiency, enable precision targeting of tumors, lessen side effects compared to conventional treatments, and streamline the patient care process. Founded in 2016 and headquartered in Zhubei, Taiwan, Heron Neutron Medical Corp. continues to shape the market for cancer therapy devices, serving global healthcare providers while advancing the adoption of innovative cancer treatment modalities.

Profile Details

Type

Common Stock

Address

No. 66-2, Shengyi 5th Road

City

Zhubei

Zip

302041

Country

Taiwan

Phone

886 3 561 9366

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.